Our sponsors

We are Merck, a vibrant science and technology company. Science is at the heart of everything we do. It drives the discoveries we make and the technologies we create. We make a positive difference to millions of people’s lives every day. Our constant curiosity and specialist approach drive our partnerships and bring new ideas to life. From advancing gene-editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices - Merck is everywhere. A desire to solve science’s toughest challenges and guarantee access to health drives our work in Life Science.

A commitment to consistency and reliability underpins our products and technologies. As a trusted supplier and partner, researchers have confidence in our products at every stage of their development journey; from bench research to product safety testing. In turn, our culture of excellence fuels the passion of those scientists and engineers as they go on to develop new technologies and world-class solutions. We are dedicated to supporting and collaborating with the global scientific community in diverse ways. The grants we award to emerging biopharma companies help bring innovation to the market, the tools and processes we develop ensure the manufacture of innovative therapies including cell and gene therapies, our STEM education programs inspire the scientists of tomorrow, and our ongoing thought-leadership ensures that our scientific knowledge is shared with the world. Our door is always open.

Bruker has been driven by the idea to always provide the best technological solution for each analytical task for more than 60 years

We are a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic solutions. Many of our products are used to detect, measure and visualize structural characteristics of chemical, biological and industrial material samples.

Our products and solutions address the rapidly evolving needs of a diverse array of customers in life science research, pharmaceuticals, biotechnology, applied markets, cell biology, clinical research, microbiology, in-vitro diagnostics, nanotechnology and materials science research.

Within the life science division our product portfolio includes magnetic resonance technology (MRMS), mass spectrometry technologies, gas and liquid chromatography, triple quadrupole mass spectrometry technologies. We have world leading technologies in Proteomics where our latest timsTOF Ultra technology is pushing the boundaries of sensitivity for single cell analysis. The timsTOF family now has a combined ESI and MALDI source allowing SpatialOMx workflows, for the latest in tissue imaging the instrument can be fitted with the MALDI-2 greatly enhancing ionisation capabilities. These technologies are complimented by our ProteoScape software, which allows real-time search and on the fly decision making.

With a rich heritage dating back hundreds of years, Cytiva brings a wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery.

We supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™.

GlycoSyn is proud to stand on a foundation of groundbreaking contributions to glycochemistry. We are co-located at the Gracefield Innovation Quarter with our Joint Venture partners, Te Kāuru - Ferrier Research Institute. Together, with our long-standing partnerships with academia and industry, we’ve been dedicated to translating glycocomics from the lab to the clinic for over 20 years.

In addition to carbohydrates, GlycoSyn has extensive experience with polymers, pharmaceutical excipients and complex small molecule chemistry. We can help you as a contract development and manufacturing organization (CDMO) or a contract research organization (CRO) with significant regulatory and GMP experience.

GlycoSyn is honoured to sponsor the 5th Australasian Glycoscience Symposium. Representing us will be Business Development Manager, Tony Davidson alongside Steven Toms, Principle Process Development Chemsit. We look forward to engaging with you about your research and helping to navigate your path to the clinic!

John Morris Group was founded in 1952 and are now recognised as one of Australia’s and New Zealand’s leading distributors of a range of specialised scientific equipment sourced from the world’s leading manufacturers.

For over 70 years John Morris Group has been the industry leader in the supply, installation & servicing of precision scientific instruments throughout Australia, NZ and the South Pacific. We offer the following Scientific Instruments Brands and services;

Lab Supply are a New Zealand family-owned and operated business, partnering with some of the worlds leading manufacturers to bring the world's best scientific technology & equipment into your laboratory!

Customers choose to work with us because regardless of where you are in the country we are here for you with speedy customer service, knowledgeable advice and onsite service.

With optimum stock levels, we offer fast delivery—24 hours for the South Island and 48 hours for the North Island—ensuring you have what you need when you need it.

Whether you are in food production, pharmaceuticals, academia, or a medical laboratory, we are your go-to source for all of your laboratory supplies.

Attending and sponsoring scientific events is important to us as we consider ourselves a key enabler and a part of the scientific community. We look forward to meeting you soon!

Protea Glycosciences is a lean glycoscience company founded with the aim of accelerating glycoscience research. We serve this mission through the provision of analytical services as well as manufacturing of standards.

Our state-of-the-art LC-MS-based analytical services enable native glycan and polysaccharide structure analyses that were previously unachievable. These services are augmented by in-house quality control standards which are commercially available for labs worldwide. Together, these equip us to help you answer some of the toughest questions in glycobiology.

Since its inception in 1875, Shimadzu’s philosophy has been to apply its thinking ‘for the well-being of humankind and the Earth’. That means real world solutions that benefit scientist, doctors and ultimately, everybody.

Our products and solutions serve the research community and analysts in diverse fields such as chemistry, molecular biology, medical science, environmental analysis and industry.

It has resulted in our leadership in spectroscopy, chromatography, mass spectrometry, environmental analysers, medical systems, aircraft equipment, semiconductors and flat panel display equipment.

It’s that thinking that brought Shimadzu direct to Australia and New Zealand since 1991 with offices and service centres in all major cities.

Established on July 1st, 2024, the Institute for Biomedicine and Glycomics (IBG) discovers, develops and commercialises drugs, vaccine and diagnostics for Infectious Diseases, Cancers and Neurological Disorders. The Institute combines the outstanding discovery and translational research, infrastructure, and training expertise of the Institute for Glycomics, the Griffith Institute for Drug Discovery (GRIDD) and biomedical teams from within the Menzies Health Institute Queensland (MHIQ) to deliver real and immediate impacts locally and globally, transforming the lives of people around the world, especially those in disadvantaged communities.

BDG Synthesis is a long running local business specialising in the custom synthesis of stable isotope labelled materials, metabolites and reference standards. They also do contract research projects in synthetic chemistry on both labelled and unlabelled targets. The website carries a suite of cannabidiol metabolites and minor cannabis constituent standards available nowhere else in the world – thanks to the smart synthetic skills of the BDG team.

Working with clients from all over the globe BDG Synthesis employs 3 PhD qualified chemists working full-time on synthetic chemistry projects and partners with Callaghan Innovation and the Ferrier Research Institute for analysis of their products.

There are over 600 specialist compounds available for immediate purchase in their extensive chemical catalogue which can be found on their website bdg.co.nz

Onelab was founded in 2017 to meet the growing needs of New Zealand customers in the research, clinical, and manufacturing space.

As demands for final product testing and cost savings increase in the manufacturing space, and the continued advancements in speed, accuracy and high throughput drives our research industry, the need for high quality, well supported products are imperative to success. “results matter” was born of these values.

Onelab offers a range of products from consumables through to premium instrumentation, to customers involved in the laboratory and manufacturing space. The company is 100% New Zealand owned and lives by these values:

• Passionate people with the right expertise
• Providing the best fit-for-purpose products available globally
• Adding value to our customers in every interaction
• Symbiotic and sustainable relationships with our customers and suppliers

GlycoNZ Ltd is a New Zealand based subsidiary of Kode Biotech Ltd, supplying a large >1000 range of glycoconjugates for glycobiology research. Our range of products and services is orientated to the study of the functions of carbohydrates, carbohydrate-binding proteins in biological processes, and the discovery of new carbohydrate-mediated interactions. Our high purity primary products are ~20 kDa polyacrylamide backbone constructs with 20 mol% glycan and presented in either label free form (PA-series) or modified with biotin (BP-series) or fluorophore (FP-series). Additionally, spacer-arm biotinylated saccharides (BM-series) are also available. Specialist products and services include affinity resins, custom syntheses in milligram to 100-gram scale, glycochips and Kode Technology synthetic glycolipids (Kode eBook https://hdl.handle.net/2292/62953 )

Our products are commercially available directly from GlycoNZ and R&D level (mg) supplies in the US are through Merck.

From single positional isomer analytical standards to milligram and gram-scale reagents that are excellent building blocks for glycoconjugate synthesis or further modification, GlyTech, Inc. manufactures high-quality N-linked glycans in practical amounts for any application. Our catalog of oligosaccharides includes bi-, tri-, and tetra-antennary, bisecting GlcNAc, mixed sialylation, and high mannose structures.

We are also experts in glycopeptide SPPS and chemical glycosylation with nearly 20 years’ experience aiding academic, biotech, and biopharma customers with the design and production of high quality, homogenous glycoconjugates not only to support laboratory R&D but also pre-clinical and clinical development.”

Lectenz Bio specializes in glyco-research tools and services for the life sciences. Spun out of the Complex Carbohydrate Research Center at the University of Georgia, our expert team has deep roots in the world of glycobiology, keeping innovative science at the heart of all our operations. Our products include novel glycan detection reagents, profiling kits, columns, and enzymes, offering flexible, easy-to-use solutions for your workflow needs. We maintain a strong Quality Management System, ensuring all of our products are QC tested to rigorous standards. Through our services, we combine decades of experience with our novel glycoscience catalog to help clients find solutions and advance their projects. As a customer-centric company, we constantly strive to provide exceptional, high-quality tools and services for all of our customers.

The aim of the foundation is to promote worldwide progress of glycoscience, especially that of glycoconjugates.

The Royal Society of Chemistry is a society publisher whose mission is to advance excellence in the chemical sciences. We re-invest all surplus back into the global scientific community, providing ongoing support for authors, researchers and educators in every field of chemistry and related disciplines.

Molecular Omics publishes high-quality research in the -omics sciences, welcoming scientific research based on the application of any -omics technology to solve important chemical or biological problems. This includes combining different omics platforms encompassing genomics, transcriptomics, proteomics, metabolomics and other specialised areas such as glycomics and lipidomics.

Organic & Biomolecular Chemistry publishes original and high impact research and reviews in organic chemistry, welcoming research that shows new or significantly improved protocols or methodologies in total synthesis, synthetic methodology, physical and theoretical organic chemistry along with significant advances in chemical biology, catalysis, supramolecular or macromolecular chemistry.

Thermo Fisher Scientific is the world leader in serving science, enabling customers to make the world healthier, cleaner and safer. Our comprehensive range includes high-end analytical and process instrumentation, laboratory equipment, a complete range of consumables, chemicals and reagents as well as the service and support to optimise your results. We’ve combined sales and service teams to make it easier for customers to connect with all our capabilities and leading global brands. Our local team of more than 1000 employees are working together across Australia and New Zealand to provide unparalleled industry, product and application expertise. From research to academia; diagnostics, medical and healthcare; biotechnology and pharmaceutical; food, diary and beverage; manufacturing and utilities; heavy industry, minerals, mining & petrochemical; environmental gas, water and assessment technologies.